How do bad bacteria find entry points in the body to cause infection? This question is fundamental for infectious disease experts and people who study bacteria.
FDA approves AstraZeneca’s Imfinzi for LS-SCLC treatment
The FDA also granted breakthrough status to AstraZeneca’s Imfinzi for LS-SCLC treatment. Credit: © AstraZeneca 2024. The US Food and Drug Administration (FDA) has approved
December 5, 2024